Related Experiment Video
Updated: May 19, 2026
16:05
Using Micro-Electro-Mechanical Systems (MEMS) to Develop Diagnostic Tools
Published on: October 1, 2007
Personalized medicine and education: the challenge
Jacques Haiech1, Marie-Claude Kilhoffer
1School of Biotechnology, University of Strasbourg, Strasbourg, France. haiech@unistra.fr
Croatian Medical Journal
|August 23, 2012
Summary
Personalized medicine requires a shift from reactive to predictive healthcare, necessitating new training for medical professionals. Multidisciplinary teams integrating data modeling are crucial for its successful implementation.
Area of Science:
- Life Sciences
- Medical Informatics
- Healthcare Systems
Background:
- Current medical training remains largely reactive, contrasting with the evolving predictive nature of life sciences.
- Personalized medicine represents a paradigm shift towards proactive and data-driven healthcare approaches.
Purpose of the Study:
- To highlight the transition of life sciences towards predictive modeling.
- To emphasize the necessity of new training paradigms for healthcare professionals to support personalized medicine.
Main Methods:
- Conceptual analysis of current medical training versus emerging needs.
- Discussion on the integration of quantitative models and multidisciplinary teams in healthcare.
- Identification of training challenges for personalized medicine.
Main Results:
- Life sciences are increasingly adopting quantitative and predictive models.
- Personalized medicine necessitates a move towards proactive, data-integrated healthcare.
- Effective implementation requires multidisciplinary teams, including data modelers.
Conclusions:
- Adapting medical education to incorporate predictive modeling and teamwork is essential for personalized medicine.
- Overcoming training bottlenecks is critical for the successful adoption of personalized medicine.
- A paradigm shift in healthcare training is required to realize the potential of personalized medicine.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...